On May 25, 2023, Cyclerion Therapeutics, Inc. closed the transaction. The transaction included participation from a single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.15 USD | +5.00% | +6.60% | -5.97% |
1st Jan change | Capi. | |
---|---|---|
-5.97% | 8M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CYCN Stock
- News Cyclerion Therapeutics, Inc.
- Cyclerion Therapeutics, Inc. announced that it has received $5.000001 million in funding